BPA CALL
Active75F40126F19012
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$5.7M
obligated · signed 2 weeks ago
DRUG LABELING INITIATIVE - CDER SUPPORT
Performance timeline
Start
Sep 30, 2026
End
Sep 29, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Sep 29, 2027
DELOITTE CONSULTING LLP
Contract 75F40126F19012
UEI
CKV2L9GZKJK3
Parent Company
DELOITTE CONSULTING LLP
Capabilities & Certifications
Headquarters Location
Congressional District: 08
Current Obligation
$5,692,682
Base + Exercised Options
$5,692,682
Total Ceiling Value
$5,692,682
Contract Type
FIRM FIXED PRICE
NAICS
ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES
PSC
SPECIAL STUDIES/ANALYSIS- REGULATORY
Place of Performance
Congressional District: 08
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Contract Vehicle
75F40122A00018
BPADepartment of Health and Human Services
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.